MINI FUTURE OPTIONSSCHEIN PUT - BIOGEN IDEC | Delayed Deutsche Boerse AG 01:34:39 29/05/2024 pm IST | ||
| 11.08 EUR | -0.09% |
|
| Current month | -3.82% | ||
| 1 month | -7.35% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 29/24/29 | 11.08 | -0.09% |
| 28/24/28 | 11.09 | +0.45% |
| 27/24/27 | 11.04 | -0.45% |
| 24/24/24 | 11.09 | +0.27% |
| 23/24/23 | 11.06 | +6.35% |
Delayed Quote Deutsche Boerse AG
Last update May 29, 2024 at 01:34 pm IST
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BIOGEN INC. |
| Issuer | DZ BANK |
| WKN | DJ5S1G |
| ISIN | DE000DJ5S1G9 |
| Date issued | 26/10/2023 |
| Strike | 336.5 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 7.86 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 13.88 € |
|---|---|
| Lowest since issue | 6.28 € |
| Spread | 0.09 € |
| Spread % | 0.81% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
218.7
USD
Average target price
286.1
USD
Spread / Average Target
+30.78%
- Stock Market
- Certificates
- Certificat
